Mollicutes

Testing.com Announces Best Free STD Testing Organizations in Des Moines, Iowa

Retrieved on: 
Friday, March 12, 2021
Infectious causes of cancer, Sexually transmitted diseases and infections, Chlamydiae, Gonorrhea, Sexually transmitted infection, Chlamydia, Medical specialties, Polk County, Polk, Mollicutes, Mycoplasmataceae

SEATTLE, March 12, 2021 /PRNewswire-PRWeb/ -- Testing.com , a trusted informational guide for medical lab testing and at-home screening, has published a report on the increasing STD cases and resources for addressing this issue in Des Moines, including top local organizations with free or low-cost health screening options for residents.

Key Points: 
  • SEATTLE, March 12, 2021 /PRNewswire-PRWeb/ -- Testing.com , a trusted informational guide for medical lab testing and at-home screening, has published a report on the increasing STD cases and resources for addressing this issue in Des Moines, including top local organizations with free or low-cost health screening options for residents.
  • According to the report, despite Iowa being a rural state, incidences of STDs are following the national trend.
  • Chlamydia infections have increased for the last five years in Polk County, according to the Polk County Health Department's Chlamydia 2015-2019 Polk County Report while The Polk County Health Department's Gonorrhea 2015-2019 Polk County Report documented a startling 121.8% increase in gonorrhea cases.
  • After an encouraging drop of 32.4% in total syphilis cases in 2018, Polk County cases took a dramatic jump in 2019.

Mycoplasma Testing Market Is Projected to Reach $1.59 Billion by 2027 | CAGR: 12.8%: Polaris Market Research

Retrieved on: 
Monday, March 1, 2021
Mollicutes, Sexually transmitted diseases and infections, Infertility, Infectious causes of cancer, Bacterial vaginosis, Mycoplasma, Mycoplasmataceae, Taxa, Market research, Market share

NEW YORK, March 1, 2021 /PRNewswire/ -- The global mycoplasma testing market expected to reach USD 1.59 billion by 2027according to a new study conducted by Polaris Market Research.

Key Points: 
  • NEW YORK, March 1, 2021 /PRNewswire/ -- The global mycoplasma testing market expected to reach USD 1.59 billion by 2027according to a new study conducted by Polaris Market Research.
  • The rise in cell culture contamination is among one of the key factors that foster the growth of the global market for mycoplasma testing.
  • Get Full Research Summary on Mycoplasma Testing Market: https://www.polarismarketresearch.com/industry-analysis/mycoplasma-testi...
    North America accounted for the largest share of the global mycoplasma testing market and is projected to expand its market share during the forecast period.
  • Feel Free To Ask Our Industry Experts At: https://www.polarismarketresearch.com/industry-analysis/mycoplasma-testi...
    Polaris Market Research has segmented themycoplasma testing market report on the basis ofproduct, technology, application, end-use, and region:
    Mycoplasma Testing, Product Outlook (Revenue USD Million, 2016 2027)

Outlook on the Mycoplasma Testing Global Market to 2027 - by Product, Technology, Application, End-use and Regions

Retrieved on: 
Monday, February 22, 2021
Sexually transmitted diseases and infections, Mollicutes, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Taxa

5.4.3.1.

Key Points: 
  • 5.4.3.1.
  • Global Mycoplasma Testing Market, by Nucleic Acid Detection Kits, by Region, 2016-2027 (USD Million)
    7.5.1.
  • Global Mycoplasma Testing Market, by End of Production Cells Testing, by Region, 2016-2027 (USD Million)
    8.6.1.
  • Global Mycoplasma Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2016-2027 (USD Million)

Worldwide Mycoplasma Testing Industry to 2027 - Growing Concerns Over Cell Contamination Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 18, 2021
Health, Pharmaceutical, Mollicutes, Natural sciences, Sexually transmitted diseases and infections, Laboratory techniques, Branches of biology, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Assay, ELISA, Polymerase chain reaction

The global mycoplasma testing market expected to reach USD 1.59 billion by 2027, according to the study.

Key Points: 
  • The global mycoplasma testing market expected to reach USD 1.59 billion by 2027, according to the study.
  • Based on technology, the global mycoplasma testing industry is further bifurcated into PCR, ELISA, direct assay, indirect assay, microbial culture techniques, and enzymatic methods.
  • Based on application, the mycoplasma testing industry is further bifurcated into cell line, virus, end of production cells, and others.
  • Based on end-use, the market for mycoplasma testing is further bifurcated into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others.

Global Mycoplasma Testing Markets, 2020-2025 - Globalization of Clinical Trials and R&D and Harmonization of Regulations Resulting in Increased Outsourcing

Retrieved on: 
Monday, December 7, 2020
Mollicutes, Sexually transmitted diseases and infections, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Natural sciences, Assay, Taxa

The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.

Key Points: 
  • The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
  • The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period.

Mycoplasma Testing Market worth $1,095 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 11, 2020
Sexually transmitted diseases and infections, Mollicutes, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Natural sciences, Assay, Taxa

The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019

Key Points: 
  • The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=136509856
    The global mycoplasma testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.
  • In 2019, North America accounted for the largest share of the global mycoplasma testing market.

Mycoplasma Testing Market worth $1,095 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 11, 2020
Sexually transmitted diseases and infections, Mollicutes, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Natural sciences, Assay, Taxa

The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019

Key Points: 
  • The assays, kits, & reagents products segment accounted for the largest share of the mycoplasma testing market, by product & service segment, in 2019
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=136509856
    The global mycoplasma testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.
  • In 2019, North America accounted for the largest share of the global mycoplasma testing market.

Analysis on Impact of COVID19-Global Mycoplasma Testing Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and ATCC | Technavio

Retrieved on: 
Friday, May 15, 2020
Biotechnology, Pharmaceutical, Health, Mycoplasma, Taxa, Life sciences, Mollicutes, Sexually transmitted diseases and infections, Health, Infectious causes of cancer, Bacterial vaginosis, Acholeplasma laidlawii, Biopharmaceutical, Acholeplasma

The global mycoplasma testing market size is expected to grow by USD 445.57 million as per Technavio.

Key Points: 
  • The global mycoplasma testing market size is expected to grow by USD 445.57 million as per Technavio.
  • However, the global outbreak of coronavirus is expected to have a neutral impact on the growth of the mycoplasma testing market during the forecast period.
  • In addition, the growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies is anticipated to boost the growth of the mycoplasma testing market.
  • Common mycoplasma species such as Acholeplasma laidlawii, Mycoplasma arginini, Mycoplasma bovis, Mycoplasma fermentans, and Mycoplasma salivarium have been identified as contamination in cell cultures and the biopharmaceutical processes.